$ Value
$0
Shares
9,750
Price
$0
Filed
Oct 21
Insider
Name
Brooks Gabriel
Title
Chief Medical Officer
CIK
0001997809
Roles
Transaction Details
Transaction Date
2025-10-18
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
19,500
Footnotes
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. | Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 30, 2025. | This sale was made to cover withholding taxes following the vesting of previously granted RSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks. | The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.
Filing Info
Brooks Gabriel's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-29 | SLDB | A | $0 |
| 2025-10-20 | SLDB | ▼ | $17K |
| 2025-10-18 | SLDB | M | — |
| 2025-10-18 | SLDB | M | $0 |
| 2025-08-14 | SLDB | A | $0 |
| 2025-08-14 | SLDB | A | $0 |
Other Insiders at SLDB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SMITH IAN F | — | — | 2026-04-02 |
|
Howton David T
Chief Operating Officer
|
— | — | 2026-01-29 |
|
Cumbo Alexander
President and CEO
|
— | — | 2026-01-29 |
|
Tan Kevin
CFO & Treasurer
|
— | — | 2026-01-29 |
|
Hanrahan Jessie
Chief Regulatory Officer
|
— | — | 2026-01-29 |
|
Herzich Paul
Chief Technology Officer
|
— | — | 2026-01-29 |
|
Brooks Gabriel
Chief Medical Officer
|
— | — | 2026-01-29 |